Skip to content

Author

Sheraz Khan

We have 1 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Can agentic AI dent Eroom's Law? Large reasoning models across the drug discovery and development pipeline.

This review discusses agentic AI applications across the drug development continuum, from target discovery to post-market surveillance, and highlights three near-term use cases: algorithmic drug repurposing, informed consent support and automated drafting of regulatory documents.

Sheraz Khan, John G. Samuelsson, Xue-Mei Cai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.